Rayas Emmanuel Giovanni, Winckler Christopher, Bolleter Scotty, Stringfellow Michael, Miramontes David, Shumaker Joi, Lewis Alan, Wampler David
University of Texas Health Science Center at San Antonio, Department of Emergency Health Sciences, 4522 Fredericksburg Dr. Suite 101, San Antonio, TX 78201, United States.
University of Texas Health Science Center at San Antonio, Department of Emergency Health Sciences, 4522 Fredericksburg Dr. Suite 101, San Antonio, TX 78201, United States.
Resuscitation. 2022 Jan;170:11-16. doi: 10.1016/j.resuscitation.2021.10.041. Epub 2021 Nov 5.
Intraosseous (IO) vascular access is a well-established method for fluid and drug administration in the critically ill. The Food and Drug Administration has approved adult IO access at the proximal humerus, proximal tibia, and the sternum; all three sites have significant limitations. The Distal Femur is away from the chest, with high flow rates. The objective of this study was to evaluate the distal femur site during resuscitation of adult out-of-hospital cardiac arrest.
A retrospective analysis of adult out of hospital cardiac arrest patients treated by the San Antonio Fire Department. IO access was obtained by first-responders (paramedics or EMT-basic) or EMS paramedics. All resuscitation attempts from 2017 to 2018 data were analyzed. The protocol did not dictate the preference of IO site. The primary measure: number of OHCA patients in each subgroup: IO femur, IO humerus, IO tibia. Secondary measures: paramedic or basic operator, dislodgement rate, and total fluid infused.
There were 2,198 patients meeting inclusion criteria: 888 femur, 696 humerus, 432 tibia. Distal femur increased 2.5 times in the 2018 cohort compared to the 2017 cohort, with a corresponding decrease in humerus (factor of 0.29). Proximal tibia remained unchanged. Dislodgement rates and total infusion (ml) remained unchanged.
The distal femur IO was feasible and associated with similar measured performance parameters as other IO sites in adult OHCA for both advanced and basic life support personnel.
骨内(IO)血管通路是危重症患者液体和药物输注的一种成熟方法。美国食品药品监督管理局已批准在肱骨近端、胫骨近端和胸骨处进行成人IO穿刺;这三个部位均有明显局限性。股骨远端远离胸部,流速高。本研究的目的是评估成人院外心脏骤停复苏期间股骨远端穿刺部位。
对圣安东尼奥消防局治疗的成人院外心脏骤停患者进行回顾性分析。IO穿刺由急救人员(护理人员或初级急救医疗技术员)或急救医疗服务护理人员完成。分析了2017年至2018年所有复苏尝试的数据。该方案未规定IO穿刺部位的偏好。主要指标:各亚组(IO股骨、IO肱骨、IO胫骨)的院外心脏骤停患者数量。次要指标:护理人员或初级急救医疗技术员、移位率和总输液量。
有2198例患者符合纳入标准:888例股骨穿刺、696例肱骨穿刺、432例胫骨穿刺。与2017年队列相比,2018年队列中股骨远端穿刺增加了2.5倍,肱骨穿刺相应减少(系数为0.29)。胫骨近端保持不变。移位率和总输液量(毫升)保持不变。
对于高级和基础生命支持人员,在成人院外心脏骤停中,股骨远端IO穿刺是可行的,且与其他IO穿刺部位的测量性能参数相似。